Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AvePoint (AVPT) Research & Development: 2020-2025

Historic Research & Development for AvePoint (AVPT) over the last 5 years, with Sep 2025 value amounting to $13.9 million.

  • AvePoint's Research & Development rose 8.55% to $13.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.5 million, marking a year-over-year increase of 15.96%. This contributed to the annual value of $48.7 million for FY2024, which is 34.01% up from last year.
  • AvePoint's Research & Development amounted to $13.9 million in Q3 2025, which was up 7.53% from $13.0 million recorded in Q2 2025.
  • AvePoint's Research & Development's 5-year high stood at $19.6 million during Q3 2021, with a 5-year trough of $3.9 million in Q2 2021.
  • Its 3-year average for Research & Development is $11.3 million, with a median of $12.5 million in 2024.
  • Per our database at Business Quant, AvePoint's Research & Development surged by 554.28% in 2021 and then crashed by 53.10% in 2022.
  • AvePoint's Research & Development (Quarterly) stood at $4.5 million in 2021, then spiked by 66.57% to $7.5 million in 2022, then grew by 25.30% to $9.4 million in 2023, then soared by 36.81% to $12.9 million in 2024, then grew by 8.55% to $13.9 million in 2025.
  • Its Research & Development stands at $13.9 million for Q3 2025, versus $13.0 million for Q2 2025 and $12.7 million for Q1 2025.